|
|
| Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease. |
Boden WE, Hartigan PM, Mancini J, Teo KK, Chaitman BR, Maron DJ, Kostuk WJ, Hartigan JA, Dada M, Spertus JA, Bates ER, Weintraub WS; COURAGE Trial Investigators.
Am J Cardiol. 2020 Sep 1;130:1-6. doi: 10.1016/j.amjcard.2020.05.046. |
|
|
| Independent and cumulative association of clinical and morphological heart failure with long-term outcome after percutaneous coronary intervention. |
Kimura M, Kohno T, Sawano M, Heidenreich PA, Ueda I, Takahashi T, Matsubara T, Ueno K, Hayashida K, Yuasa S, Ohki T, Fukuda K, Kohsaka S.
J Cardiol. 2020 Sep 1:S0914-5087(20)30208-2. doi: 10.1016/j.jjcc.2020.06.014. |
|
|
| Cardiac procedural deferral during the coronavirus (COVID-19) pandemic. |
Yong CM, Ang L, Welt FGP, Gummidipundi S, Henry TD, Pinto DS, Cox D, Wang P, Asch S, Mahmud E, Fearon WF; Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology (ACC) Interventional Council.
Catheter Cardiovasc Interv. 2020 Sep 3. doi: 10.1002/ccd.29262. |
|
|
| Apelin increases atrial conduction velocity, refractoriness, and prevents inducibility of atrial fibrillation. |
Kim YM, Lakin R, Zhang H, Liu J, Sachedina A, Singh M, Wilson E, Perez M, Verma S, Quertermous T, Olgin J, Backx PH, Ashley EA.
JCI Insight. 2020 Sep 3;5(17):126525. doi: 10.1172/jci.insight.126525. |
|
|
| Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial. |
Okada K, Honda Y, Kitahara H, Ikutomi M, Kameda R, Brooke Hollak M, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T; ABSORB Japan Investigators.
Int J Cardiol Heart Vasc. 2020 Sep 4;31:100623. doi: 10.1016/j.ijcha.2020.100623. |
|
|
| Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank. |
Huang CY, Li LH, Hsu WT, Cheng YC, Nicholson MW, Liu CL, Ting CY, Ko HW, Syu SH, Wen CH, Yan Z, Huang HP, Su HL, Chiang PM, Shen CN, Chen HF, Yen BLJ, Lu HE, Hwang SM, Chiou SH, Ho HN, Wu JY, Kamp TJ, Wu JC, Hsieh PCH.
J Biomed Sci. 2020 Sep 4;27(1):92. doi: 10.1186/s12929-020-00682-7. |
|
|
| Chromosome 1q21.2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarction. |
Saw J, Yang ML, Trinder M, Tcheandjieu C, Xu C, Starovoytov A, Birt I, Mathis MR, Hunker KL, Schmidt EM, Jackson L, Fendrikova-Mahlay N, Zawistowski M, Brummett CM, Zoellner S, Katz A, Coleman DM, Swan K, O'Donnell CJ; Million Veteran Program, Zhou X, Li JZ, Gornik HL, Assimes TL, Stanley JC, Brunham LR, Ganesh SK.
Nat Commun. 2020 Sep 4;11(1):4432. doi: 10.1038/s41467-020-17558-x. |
|
|
| Associations Between Depressive Symptoms and HFpEF-Related Outcomes. |
Chandra A, Alcala MAD, Claggett B, Desai AS, Fang JC, Heitner JF, Liu J, Pitt B, Solomon SD, Pfeffer MA, Lewis EF.
JACC Heart Fail. 2020 Sep 4:S2213-1779(20)30386-3. doi: 10.1016/j.jchf.2020.06.010. |
|
|
| iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy. |
Briganti F, Sun H, Wei W, Wu J, Zhu C, Liss M, Karakikes I, Rego S, Cipriano A, Snyder M, Meder B, Xu Z, Millat G, Gotthardt M, Mercola M, Steinmetz LM.
Cell Rep. 2020 Sep 8;32(10):108117. doi: 10.1016/j.celrep.2020.108117. |
|
|
| Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop. |
Greenland P, Michos ED, Redmond N, Fine LJ, Alexander KP, Ambrosius WT, Bibbins-Domingo K, Blaha MJ, Blankstein R, Fortmann SP, Khera A, Lloyd-Jones DM, Maron DJ, Min JK, Muhlestein JB, Nasir K, Sterling MR, Thanassoulis G.
JACC Cardiovasc Imaging. 2020 Sep 11:S1936-878X(20)30650-1. doi: 10.1016/j.jcmg.2020.06.042. |
|
|
| Transcriptomic signatures across human tissues identify functional rare genetic variation. |
Ferraro NM, Strober BJ, Einson J, Abell NS, Aguet F, Barbeira AN, Brandt M, Bucan M, Castel SE, Davis JR, Greenwald E, Hess GT, Hilliard AT, Kember RL, Kotis B, Park Y, Peloso G, Ramdas S, Scott AJ, Smail C, Tsang EK, Zekavat SM, Ziosi M, Aradhana; TOPMed Lipids Working Group, Ardlie KG, Assimes TL, Bassik MC, Brown CD, Correa A, Hall I, Im HK, Li X, Natarajan P; GTEx Consortium, Lappalainen T, Mohammadi P, Montgomery SB, Battle A.
Science. 2020 Sep 11;369(6509):eaaz5900. doi: 10.1126/science.aaz5900. |
|
|
| Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity. |
McKeithan WL, Feyen DAM, Bruyneel AAN, Okolotowicz KJ, Ryan DA, Sampson KJ, Potet F, Savchenko A, Gómez-Galeno J, Vu M, Serrano R, George AL Jr, Kass RS, Cashman JR, Mercola M.
Cell Stem Cell. 2020 Sep 12:S1934-5909(20)30399-4. doi: 10.1016/j.stem.2020.08.003. |
|
|
| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. |
Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D; EXPLORER-HCM study investigators.
Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. |
|
|
| Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial. |
Rymer JA, Mulder H, Smolderen KG, Hiatt WR, Conte MS, Berger JS, Norgren L, Mahaffey KW, Baumgartner I, Fowkes FG, Katona BG, Rockhold F, Jones WS, Patel MR.
J Am Heart Assoc. 2020 Sep 13:e016573. doi: 10.1161/JAHA.120.016573. |
|
|
| Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry. |
Canepa M, Fumagalli C, Tini G, Vincent-Tompkins J, Day SM, Ashley EA, Mazzarotto F, Ware JS, Michels M, Jacoby D, Ho CY, Olivotto I; SHaRe Investigators.
Circ Heart Fail. 2020 Sep;13(9):e007230. doi: 10.1161/CIRCHEARTFAILURE.120.007230. |
|
|
| Procedural Patterns and Safety of Atrial Fibrillation Ablation: Findings From Get With The Guidelines-Atrial Fibrillation. |
Loring Z, Holmes DN, Matsouaka RA, Curtis AB, Day JD, Desai N, Ellenbogen KA, Feld GK, Fonarow GC, Frankel DS, Hurwitz JL, Knight BP, Joglar JA, Russo AM, Sidhu MS, Turakhia MP, Lewis WR, Piccini JP.
Circ Arrhythm Electrophysiol. 2020 Sep;13(9):e007944. doi: 10.1161/CIRCEP.119.007944. |
|
|
| Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID Trial. |
Fudim M, Hopley CW, Huang Z, Kavanagh S, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Katona BG, Mahaffey KW, Norgren L, Ostrom C, Patel MR, Jones WS, Hiatt WR.
Circ Cardiovasc Qual Outcomes. 2020 Sep;13(9):e006512. doi: 10.1161/CIRCOUTCOMES.120.006512. |
|
|
| A Novel Recessive Mutation in SPEG Causes Early Onset Dilated Cardiomyopathy. |
Levitas A, Muhammad E, Zhang Y, Perea Gil I, Serrano R, Diaz N, Arafat M, Gavidia AA, Kapiloff MS, Mercola M, Etzion Y, Parvari R, Karakikes I.
PLoS Genet. 2020 Sep 14;16(9):e1009000. doi: 10.1371/journal.pgen.1009000. |
|
|
| Current Evidence and Recommendations for Coronary CTA First in Evaluation of Stable Coronary Artery Disease. |
Poon M, Lesser JR, Biga C, Blankstein R, Kramer CM, Min JK, Noack PS, Farrow C, Hoffman U, Murillo J, Nieman K, Shaw LJ.
J Am Coll Cardiol. 2020 Sep 15;76(11):1358-1362. doi: 10.1016/j.jacc.2020.06.078. |
|
|
| Association of Adverse Pregnancy Outcomes With Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women. |
Søndergaard MM, Hlatky MA, Stefanick ML, Vittinghoff E, Nah G, Allison M, Gemmill A, Van Horn L, Park K, Salmoirago-Blotcher E, Sattari M, Sealy-Jefferson S, Shadyab AH, Valdiviezo C, Manson JE, Parikh NI.
JAMA Cardiol. 2020 Sep 16. doi: 10.1001/jamacardio.2020.4097. |
|
|
| A Path Forward. |
Elkind MSV, Harrington RA, Lloyd-Jones DM.
J Am Heart Assoc. 2020 Sep 17:e018288. doi: 10.1161/JAHA.120.019210. |
|
|
| Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology: Endorsed by the American College of Cardiology. |
Lakkireddy DR, Chung MK, Deering TF, Gopinathannair R, Albert CM, Epstein LM, Harding CV, Hurwitz JL, Jeffery CC, Krahn AD, Kusumoto FM, Lampert R, Mansour M, Natale A, Patton KK, Seiler A, Shah MJ, Wang PJ, Russo AM.
Heart Rhythm. 2020 Sep;17(9):e242-e254. doi: 10.1016/j.hrthm.2020.06.012. |
|
|
| Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program. |
Neuen BL, Ohkuma T, Neal B, Matthews DR, de Zeeuw D, Mahaffey KW, Fulcher G, Blais J, Li MBiostat Q, Jardine MJ, Perkovic V, Wheeler DC.
Am J Kidney Dis. 2020 Sep 21:S0272-6386(20)30923-9. doi: 10.1053/j.ajkd.2020.06.018. |
|
|
| Decreased lymphatic HIF-2α accentuates lymphatic remodeling in lymphedema. |
Jiang X, Tian W, Granucci EJ, Tu AB, Kim D, Dahms P, Pasupneti S, Peng G, Kim Y, Lim AH, Espinoza FH, Cribb M, Dixon JB, Rockson SG, Semenza GL, Nicolls MR.
J Clin Invest. 2020 Sep 21:136164. doi: 10.1172/JCI136164. |
|
|
| Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE FH Registry. |
de Ferranti SD, Shrader P, Linton MF, Knowles JW, Hudgins LC, Benuck I, Kindt I, O'Brien EC, Peterson AL, Ahmad ZS, Clauss S, Duell PB, Shapiro MD, Wilemon K, Gidding SS, Neal W.
J Pediatr. 2020 Sep 22:S0022-3476(20)31175-6. doi: 10.1016/j.jpeds.2020.09.042. |
|
|
| Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. |
Gertz M, Adams D, Ando Y, Beirão JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G.
BMC Fam Pract. 2020 Sep 23;21(1):198. doi: 10.1186/s12875-020-01252-4. |
|
|
| Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound. |
Moayedi Y, Fan CPS, Tremblay-Gravel M, Miller RJ, Kawana M, Henricksen E, Parizo J, Wainwright R, Fearon WF, Ross HJ, Khush KK, Teuteberg JJ.
Clin Transplant. 2020 Sep 24:e14098. doi: 10.1111/ctr.14098. |
|
|
| Adjustment For Social Risk Factors Does Not Meaningfully Affect Performance On Medicare's MIPS Clinician Cost Measures. |
Sandhu AT, Bhattacharya J, Lam J, Bounds S, Luo B, Moran D, Uwilingiyimana AS, Fenson D, Choradia N, Do R, Feinberg L, MaCurdy T, Nagavarapu S.
Health Aff (Millwood). 2020 Sep;39(9):1495-1503. doi: 10.1377/hlthaff.2020.00440. |
|
|
| Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm. |
Pedroza AJ, Tashima Y, Shad R, Cheng P, Wirka R, Churovich S, Nakamura K, Yokoyama N, Cui JZ, Iosef C, Hiesinger W, Quertermous T, Fischbein MP.
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2195-2211. doi: 10.1161/ATVBAHA.120.314670. |
|
|
|
Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events.
|
Yu J, Zhou Z, Mahaffey KW, Matthews DR, Neuen BL, Heerspink HJL, Jardine MJ, Li J, Perkovic V, Neal B, Arnott C.
Int J Cardiol. 2020 Sep 24:S0167-5273(20)33831-6. doi: 10.1016/j.ijcard.2020.09.050. |
|
|
| An assessment of the role of vinculin loss of function variants in inherited cardiomyopathy. |
Hawley MH, Almontashiri N, Biesecker LG, Berger N, Chung WK, Garcia J, Grebe TA, Kelly MA, Lebo MS, Macaya D, Mei H, Platt J, Richard G, Ryan A, Thomson KL, Vatta M, Walsh R, Ware JS, Wheeler M, Zouk H, Mason-Suares H, Funke B.
Hum Mutat. 2020 Sep;41(9):1577-1587. doi: 10.1002/humu.24061. |
|
|
| Healthy lifestyle and risk of incident heart failure with preserved and reduced ejection fraction among post-menopausal women: The Women's Health Initiative study. |
Noel CA, LaMonte MJ, Roberts MB, Pearlman DH, Banack H, Allison M, Shadyab AH, Haring B, Laddu D, Martin LW, Nguyen PK, Manson JE, Eaton CB.
Prev Med. 2020 Sep;138:106155. doi: 10.1016/j.ypmed.2020.106155. |
|
|
| Evaluation of a Health Care Performance Improvement Initiative to Facilitate Optimal Clinical Outcomes in Patients Receiving Ventricular Assist Device Support. |
Lockard KL, Dunn E, Kunz N, Pearsol A, Schaub RD Jr, Severyn DA, Lohmann D, McCall M, Morelli B, Teuteberg JJ, Kormos RL, Sciortino CM, Dew MA.
Prog Transplant. 2020 Sep 28:1526924820958129. doi: 10.1177/1526924820958129. |
|
|
| Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran Program. |
Klarin D, Verma SS, Judy R, Dikilitas O, Wolford BN, Paranjpe I, Levin MG, Pan C, Tcheandjieu C, Spin JM, Lynch J, Assimes TL, Nyrønning LÅ, Mattsson E, Edwards TL, Denny J, Larson E, Lee MTM, Carrell D, Zhang Y, Jarvik GP, Gharavi AG, Harley J, Mentch F, Pacheco JA, Hakonarson H, Skogholt AH, Thomas L, Gabrielsen ME, Hveem K, Nielsen JB, Zhou W, Fritsche L, Huang J, Natarajan P, Sun YV, DuVall SL, Rader DJ, Cho K, Chang KM, Wilson PWF, O'Donnell CJ, Kathiresan S, Scali ST, Berceli SA, Willer C, Jones GT, Bown MJ, Nadkarni G, Kullo IJ, Ritchie M, Damrauer SM, Tsao PS.
Circulation. 2020 Sep 28. doi: 10.1161/CIRCULATIONAHA.120.047544. |
|
|
| Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE Trial. |
| Oshima M, Neuen BL, Li J, Perkovic V, Charytan DM, de Zeeuw D, Edwards R, Greene T, Levin A, Mahaffey KW, De Nicola L, Pollock C, Rosenthal N, Wheeler DC, Jardine MJ, Heerspink HJL.J Am Soc Nephrol. 2020 Sep 30:ASN.2020050723. doi: 10.1681/ASN.2020050723. |
|
|
|
|
|
|
